Example: marketing
NSSG Chemotherapy Protocol
INPATIENT regimen (Etoposide/ Doxorubicin/ Vincristine ) ETOPOSIDE IV infusion in 500 mL sodium chloride 0.9% over 24 hours. Replace bag promptly daily for a continuous infusion over 96 hours. DOXORUBICIN and VINCRISTINE are mixed together, made up to 48 mL with sodium chloride 0.9% IV infusion and administered via a LV infusor over 96 hours.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
CYCLOPHOSPHAMIDE / BORTEZOMIB/ …
nssg.oxford-haematology.org.ukMyeloma group This is a controlled document and therefore must not be changed of MM.11 CyBorDex- Amyloidosis Authorised by …
Cyclophosphamide priming prior to PBSC harvest
nssg.oxford-haematology.org.ukDepartment of Clinical Haematology Oxford BMT Programme B.2.20b Page 1 of 3 May 2017 V.5.4 Cyclo prime for Myeloma PSBC Harvest Authorised by: Dr Karthik Ramasamy
ATTENUATED CYCLOPHOSPHAMIDE, THALIDOMIDE & …
nssg.oxford-haematology.org.ukMyeloma group This is a controlled document and therefore must not be changed MM.9 CTD - attenuated Authorised by Myeloma lead Dr. Karthik Ramasamy July 2017
Guidelines for the Management of Hypomagnesaemia …
nssg.oxford-haematology.org.ukDepartment of Clinical Haematology H.95 Page 2 of 5 November 2015 V.1.0. Guidelines for the management of hypomagnesaemia in Adult Clinical Haematology
Oxford Myeloma Group
nssg.oxford-haematology.org.ukMM.50 VTDPACE/DTPACE Authorised by Myeloma lead Dr. Karthik Ramasamy June 2022 V. 2.0 of 10 Days Drug Dose Route Comments 1 to 4 Dexamethasone 40 mg daily Oral Continuous daily/ If PBSC harvest planned only for days 1 to 4 Thalidomide (See note below) Start 50 mg and increase up to 100 mg as tolerated Oral Nocte 1 to 4
MATRix (High dose METHOTREXATE, high dose CYTARABINE ...
nssg.oxford-haematology.org.uk- Reduce thiotepa dose to 75% - Reduce methotrexate to 2g/m2 Haematological toxicity In case if inadequate bone marrow recovery (i.e. neutrophils < 1.5x109/L and platelets < 90x109/L on the intended day of re-treatment, delay cycle until counts satisfactory. Doses of the chemotherapy
ISATUXIMAB WITH POMALIDOMIDE AND …
nssg.oxford-haematology.org.ukvolume Initial rate Absence of infusion reaction Rate increment Maximum rate First infusion 250 mL 25 mL/ hour For 60 minutes 25 mL/hour every 30 minutes 150 mL/ hour Second infusion 250 mL 50 mL/ hour For 30 minutes 50 mL/ hour for 30 minutes then increase by 100 mL/ hr every 30 minutes 200 mL/ hour Subsequent infusions
ATRA + ARSENIC TRIOXIDE
nssg.oxford-haematology.org.ukArsenic Trioxide infusion duration may be extended up to 4 hours if vasomotor reactions, e.g. flushing, tachycardia and dizziness, are observed. If patients suffer severe symptoms or hypotension then the infusion should be stopped until recovery and then recommenced at a
High dose METHOTREXATE (high grade NHL CNS …
nssg.oxford-haematology.org.ukadults receiving high-dose methotrexate chemotherapy (doses >1g/m2) - Who develop significant deterioration in renal function (>1.5x ULN and rising, or the presence of oliguria) OR - Have toxic plasma methotrexate level AND - Have been treated with all standard rescue and supportive measures AND
ESHAP and R-ESHAP
nssg.oxford-haematology.org.uk2. Record stage of disease - contrast enhanced CT scan (neck, chest, abdomen and pelvis), ... In order to eliminate the risk of transmitting infective ... After 1-2 cycles with CT or PET-CT. Lymphoma group This is a controlled document and therefore must …
Related documents
LEARNING FROM ERROR - WHO
www.who.intVincristine: what went wrong? Vincristine, a widely used chemotherapeutic agent, should only be administered intravenously and never by any other route. Many patients receiving intravenous vincristine also receive other medication via a spinal route as part of their treatment protocol. This has led to errors where vincristine has
PRESERVATIVE FREE SOLUTION
www.accessdata.fda.govVincristine Sulfate, USP is a white to off–white powder. It is soluble in methanol, freely soluble in water, but only slightly soluble in 95% ethanol. In 98% ethanol, Vincristine Sulfate, USP has an ultraviolet . Vincristine Sulfate Injection, USP is a sterile, preservative–free, single use only solution available for
(*riTUXimab) Cyclophosphamide, DOXOrubicin, vinCRIStine ...
www.hse.ieConsider vinCRIStine dose reduction in elderly patients. Haematological: Table 2: Dose modification in haematological toxicity ANC (x10 9 /L) Platelets (x10 9 /L) Dose < 1 and/or < 75 Delay treatment until recovery. Consider treatment delay and/or adding G-CSF. Renal and Hepatic Impairment:
2020-2021 ISMP Targeted Medication Safety Best Practices ...
www.ismp.orgDispense vinCRIStine and other vinca alkaloids in a minibag of a compatible solution and not in a syringe. Rationale: The goal of this Best Practice is to ensure that vinca alkaloids are only administered by the intravenous route. Vinca alkaloids (vinBLAStine, vinorelbine, vinCRIStine,
DRUG NAME: Mitomycin
www.bccancer.bc.cavincristine have been beneficial in some patients. 1: Mitomycin BC Cancer Drug Manual ...
R-CHOP-21 / CHOP-21 - NSSG - Haematology
nssg.oxford-haematology.org.uk* Vincristine 1 mg in patients over 70 years of age. Pretreatment with steroids: Some older patients may benefit from a steroid pre-phase consisting of 7 days of oral prednisolone at a dose of 50-100 mg daily. G-CSF primary prophylaxis: Consider for all patients from day 6 for 5 or 7 days. CYCLE FREQUENCY Cycle repeats every 21 days. RESTAGING
PRINCIPLES OF CHEMOTHERAPY IN CANCER
oncologypro.esmo.orgVincristine Vinblastine Vinorelbine Mechanism of action: Bind to microtubular proteins, thus inhibit microtubule assembly resulting in dissolution of the mitotic assembly structure. M- phase specific drugs. Eribulin (Non-taxane tubulin binding agent A marine sponge product)
BC Cancer Protocol Summary for Treatment of Lymphoma …
www.bccancer.bc.caBC Cancer Protocol Summary LYCHOPR Page 1 of 5 Activated: 5 Mar 2001 Revised: 1 June 2021 (IV bag size clarified) Warning: The information contained in these documents are a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment.
University of Wisconsin – Madison Lymphoma CHOP-19 …
uwveterinarycare.wisc.eduIf in complete remission at week 19, all therapy stops and monthly re-evaluations are instituted. Total Doxorubicin dose to date: ______ mg _______ mg/m 2